Bellus Health (BLU) has a profit margin of -3.41%, below the Healthcare sector average of 14.41%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2023
Trailing 12 months ending Sep 2023
The latest profit margin for BLU is -3.41% as of September 2023. That compares with -453737.5% in the prior-year period — up 100.0% year over year. That is below the Healthcare sector average of 14.41%. Investors often review this figure alongside Bellus Health's historical trend and sector peers before judging valuation or financial health.
Over the past year, BLU's profit margin moved from -453737.5% to -3.41% — a 100.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bellus Health's valuation or profitability profile.
Against Healthcare companies, BLU currently prints -3.41% for profit margin, while the sector average sits near 14.41%. That is roughly 123.7% below the sector mean. Large gaps often invite a closer look at Bellus Health's growth, margins, and balance sheet.
Profit Margin shows how effectively Bellus Health converts resources into returns. At -3.41%, BLU may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -453737.5% in the prior-year period — up 100.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BLU's profit margin (-3.41%), review year-over-year change from -453737.5%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.